Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

MAZE

5 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in Maze Therapeutics, Inc.

Yes. Janus Henderson holds 2,858,876 shares of MAZE (Maze Therapeutics), worth $85.3M, as of its Q1 2026 13F filing. It reduced the position by 283,711 shares (-9.0%) from Q4 2025. Janus Henderson has held MAZE in every 13F on record since Q1 2025, 5 quarterly filings.

Current Value

$85.3M

Current Shares

2.9M

Total Value Change

+$71M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.9M
-9.0%
$85.3M0.0%$44.18
0
2025-Q4
Increased
3.1M
+318.0%
$130.2M0.1%$40.05
49
2025-Q3
Decreased
751,874
-46.3%
$19.5M0.0%$25.20
0
2025-Q2
Increased
1.4M
+12.4%
$17.3M0.0%$12.13
32
2025-Q1
New
1.2M
-
$14.3M0.0%$11.42
39

Other major holders of MAZE: BlackRock, Inc., Jupiter Topco LLC, Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used